CVS HEALTH CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
CVS HEALTH CORPORATION (CVS) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $7.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-10
- CVS HEALTH CORPORATION effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $7.00M, a 92.93% decline from fiscal 2024.
- CVS HEALTH CORPORATION effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was $99.00M, a 52.31% increase from fiscal 2023.
- CVS HEALTH CORPORATION effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was $65.00M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | $7.00M 10-K · filed 2026-02-10 |
| 2024-12-31 | $99.00M 10-K · filed 2026-02-10 |
| 2023-12-31 | $65.00M 10-K · filed 2026-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |